HYDIN mutation status as a potential predictor of immune checkpoint inhibitor efficacy in melanoma

Background: The advent of immune checkpoint inhibitors (ICIs) has altered the outlook for cancer treatment. The estimation of predictive biomarkers could contribute to maximizing the benefits from ICIs treatment. Here, we explored the association between HYDIN mutations (HYDIN-MUT) in melanoma and I...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Liu, Tianrui, Kuang, Chunlei, Li, Zhendong, Qiu, Xiaoyan, Chen, Wenhong, Deng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496993/
https://www.ncbi.nlm.nih.gov/pubmed/37595251
http://dx.doi.org/10.18632/aging.204925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496993/
https://www.ncbi.nlm.nih.gov/pubmed/37595251
http://dx.doi.org/10.18632/aging.204925

Ejemplares similares